{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:44:21Z","timestamp":1790361861465,"version":"4.1.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.autrev.2014.08.040","type":"journal-article","created":{"date-parts":[[2014,8,30]],"date-time":"2014-08-30T20:03:21Z","timestamp":1409429001000},"page":"23-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Obstetrical APS: Is there a place for hydroxychloroquine to improve the pregnancy outcome?"],"prefix":"10.1016","volume":"14","author":[{"given":"Arsene","family":"Mekinian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Costedoat-Chalumeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agathe","family":"Masseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Tincani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"De Caroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Alijotas-Reig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Ruffatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ales","family":"Ambrozic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Botta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Le Guern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Fritsch-Stork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Nicaise-Roland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Carbonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Carbillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Fain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9751","key":"10.1016\/j.autrev.2014.08.040_bb0005","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(10)60709-X","article-title":"Antiphospholipid syndrome","volume":"376","author":"Ruiz-Irastorza","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.040_bb0010","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1016\/j.autrev.2014.08.040_bb0015","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.040_bb0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.revmed.2012.01.003","article-title":"Pregnancy and antiphospholipid syndrome","volume":"33","author":"Costedoat-Chalumeau","year":"2012","journal-title":"Rev Med Interne"},{"issue":"9","key":"10.1016\/j.autrev.2014.08.040_bb0025","first-page":"1261","article-title":"Antiphospholipid syndrome","volume":"61","author":"Fain","year":"2011","journal-title":"Rev Prat"},{"issue":"9","key":"10.1016\/j.autrev.2014.08.040_bb0030","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/rheumatology\/ket167","article-title":"Catastrophic antiphospholipid syndrome and pregnancy: an experience of 13 cases","volume":"52","author":"Hanouna","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.040_bb0035","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/annrheumdis-2011-201167","article-title":"European registry of babies born to mothers with antiphospholipid syndrome","volume":"72","author":"Mekinian","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.040_bb0040","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jri.2012.02.004","article-title":"Outcomes and treatment of obstetrical antiphospholipid syndrome in women with low antiphospholipid antibody levels","volume":"94","author":"Mekinian","year":"2012","journal-title":"J Reprod Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.040_bb0045","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/acr.20098","article-title":"Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome","volume":"62","author":"Ruffatti","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.040_bb0050","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0961203309347794","article-title":"Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome","volume":"19","author":"Bramham","year":"2010","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.040_bb0055","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.autrev.2014.08.040_bb0060","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/art.34402","article-title":"Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies","volume":"64","author":"Lockshin","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.autrev.2014.08.040_bb0065","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1177\/0961203312440058","article-title":"The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a preliminary first year report.","volume":"21","author":"Alijotas-Reig","year":"2012","journal-title":"Lupus."},{"issue":"1","key":"10.1016\/j.autrev.2014.08.040_bb0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/ard.2011.153817","article-title":"Risk of thromboembolic events after recurrent spontaneous abortion in antiphospholipid syndrome: a case\u2013control study","volume":"71","author":"Martinez-Zamora","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.autrev.2014.08.040_bb0075","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1177\/0961203310397080","article-title":"Thrombotic events during long-term follow-up of obstetric antiphospholipid syndrome patients","volume":"20","author":"Lefevre","year":"2011","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.autrev.2014.08.040_bb0080","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.autrev.2014.05.004","article-title":"Obstetric antiphospholipid syndrome: a recent classification for an old defined disorder","volume":"13","author":"D'Ippolito","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"9","key":"10.1016\/j.autrev.2014.08.040_bb0085","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/rheumatology\/ker139","article-title":"Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case\u2013control study","volume":"50","author":"Ruffatti","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.autrev.2014.08.040_bb0090","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.autrev.2014.02.003","article-title":"14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome","volume":"13","author":"de Jesus","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.040_bb0095","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.autrev.2013.11.004","article-title":"Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis","volume":"13","author":"Reynaud","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.autrev.2014.08.040_bb0100","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.autrev.2012.12.006","article-title":"Antiphospholipid syndrome: from pathogenesis to novel immunomodulatory therapies","volume":"12","author":"Comarmond","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.autrev.2014.08.040_bb0105","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMra1112830","article-title":"The pathogenesis of the antiphospholipid syndrome","volume":"368","author":"Giannakopoulos","year":"2013","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.040_bb0110","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood-2008-03-144204","article-title":"Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers","volume":"112","author":"Rand","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2014.08.040_bb0115","doi-asserted-by":"crossref","unstructured":"Alijotas-Reig J, Vilardell-Tarres M. Is obstetric antiphospholipid syndrome a primary nonthrombotic, proinflammatory, complement-mediated disorder related to antiphospholipid antibodies? Obstet Gynecol Surv. Jan;65(1):39\u201345.","DOI":"10.1097\/OGX.0b013e3181c97809"},{"key":"10.1016\/j.autrev.2014.08.040_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002859.pub2","article-title":"Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant","volume":"2","author":"Empson","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.040_bb0125","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/rheumatology\/kep373","article-title":"Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression","volume":"49","author":"Mak","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.040_bb0130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bpobgyn.2011.10.006","article-title":"Antiphospohlipid syndrome in obstetrics","volume":"26","author":"Danza","year":"2012","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.040_bb0135","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncprheum1017","article-title":"New approaches for managing antiphospholipid syndrome","volume":"5","author":"Erkan","year":"2009","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.040_bb0140","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/aji.12114","article-title":"Management of women with recurrent pregnancy losses and antiphospholipid antibody syndrome","volume":"69","author":"Kwak-Kim","year":"2013","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.autrev.2014.08.040_bb0145","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1182\/asheducation-2007.1.136","article-title":"The antiphospholipid syndrome","author":"Rand","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.040_bb0150","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1160\/TH06-05-0287","article-title":"Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity","volume":"96","author":"Ruffatti","year":"2006","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1016\/j.autrev.2014.08.040_bb0155","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1177\/0961203307079039","article-title":"Infant perinatal thrombosis and antiphospholipid antibodies: a review","volume":"16","author":"Boffa","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2014.08.040_bb0160","unstructured":"De Carolis MP, Salvi S, Bersani I, De Carolis S. Isolated cerebral sinovenous thrombosis: a rare case of neonatal antiphospholipid syndrome. Indian Pediatr. May;49(5):411\u20132."},{"issue":"5","key":"10.1016\/j.autrev.2014.08.040_bb0165","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1191\/0961203306lu2295cr","article-title":"Neonatal antiphospholipid syndrome","volume":"15","author":"Soares Rolim","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2014.08.040_bb0170","doi-asserted-by":"crossref","unstructured":"Andreoli L, Nalli C, Motta M, Norman GL, Shums Z, Encabo S, et al. Anti-beta(2)-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4\/5: might it be the reason for their 'innocent' profile? Ann Rheum Dis. Feb;70(2):380\u20133.","DOI":"10.1136\/ard.2010.137281"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.040_bb0175","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/EDE.0b013e3181f26e3f","article-title":"Parental autoimmune diseases associated with autism spectrum disorders in offspring","volume":"21","author":"Keil","year":"2010","journal-title":"Epidemiology"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.040_bb0180","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.semarthrit.2013.07.001","article-title":"Autism spectrum disorders in babies born to mothers with antiphospholipid syndrome","volume":"43","author":"Abisror","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.08.040_bb0185","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1196\/annals.1381.009","article-title":"Autoantibodies in autism spectrum disorders (ASD)","volume":"1107","author":"Wills","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2014.08.040_bb0190","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1749-6632.2002.tb04242.x","article-title":"Neurological and neuroendocrine\u2013cytokine inter-relationship in the antiphospholipid syndrome","volume":"966","author":"Chapman","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.040_bb0195","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-510X(98)00027-6","article-title":"Anti-beta 2-glycoprotein I antibodies bind to central nervous system","volume":"156","author":"Caronti","year":"1998","journal-title":"J Neurol Sci"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.040_bb0200","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1191\/0961203303lu409oa","article-title":"Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer","volume":"12","author":"Shoenfeld","year":"2003","journal-title":"Lupus"},{"issue":"11","key":"10.1016\/j.autrev.2014.08.040_bb0205","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1191\/0961203302lu255oa","article-title":"Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies","volume":"11","author":"Shrot","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2014.08.040_bb0210","first-page":"935608","article-title":"Increased anti-phospholipid antibodies in autism spectrum disorders","author":"Careaga","year":"2013","journal-title":"Mediat Inflamm"},{"issue":"8","key":"10.1016\/j.autrev.2014.08.040_bb0215","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/0961203307079569","article-title":"Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressants","volume":"16","author":"Biggioggero","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2014.08.040_bb0220","doi-asserted-by":"crossref","unstructured":"Marder W, Ganser MA, Romero V, Hyzy MA, Gordon C, McCune WJ, et al. In utero azathioprine exposure and increased utilization of special educational services in children born to mothers with systemic lupus erythematosus. Arthritis Care Res (Hoboken). May;65(5):759\u201366.","DOI":"10.1002\/acr.21888"},{"issue":"10","key":"10.1016\/j.autrev.2014.08.040_bb0225","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/dneu.22045","article-title":"Placental regulation of maternal\u2013fetal interactions and brain development","volume":"72","author":"Hsiao","year":"2012","journal-title":"Dev Neurobiol"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.040_bb0230","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1542\/peds.2010-2846","article-title":"Prevalence of autism spectrum disorder in adolescents born weighing <2000grams","volume":"128","author":"Pinto-Martin","year":"2011","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.040_bb0235","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/0961203312465782","article-title":"Treatment of refractory obstetric antiphospholipid syndrome: the state of the art and new trends in the therapeutic management","volume":"22","author":"Alijotas-Reig","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2014.08.040_bb0240","doi-asserted-by":"crossref","unstructured":"Ruffatti A, Salvan E, Del Ross T, Gerosa M, Andreoli L, Maina A, et al. Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study. Thromb Haemost. Jul 10;112(4).","DOI":"10.1160\/TH14-03-0191"},{"issue":"25","key":"10.1016\/j.autrev.2014.08.040_bb0245","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1182\/blood-2011-02-339234","article-title":"First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss","volume":"117","author":"Bramham","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.040_bb0250","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3892\/etm.2012.743","article-title":"Effect of prednisone, aspirin, low molecular weight heparin and intravenous immunoglobulin on outcome of pregnancy in women with antiphospholipid syndrome","volume":"5","author":"Xiao","year":"2011","journal-title":"Exp Ther Med"},{"issue":"1 Pt 1","key":"10.1016\/j.autrev.2014.08.040_bb0255","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0002-9378(00)70500-X","article-title":"A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group","volume":"182","author":"Branch","year":"2000","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.040_bb0260","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/art.10957","article-title":"Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies","volume":"48","author":"Triolo","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.040_bb0265","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/jca.21229","article-title":"Plasma exchange and immunoadsorption effectively remove antiphospholipid antibodies in pregnant patients with antiphospholipid syndrome","volume":"27","author":"Bontadi","year":"2012","journal-title":"J Clin Apher"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.040_bb0270","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.autrev.2006.11.002","article-title":"Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome. A report of 9 cases and a review of the literature","volume":"6","author":"Ruffatti","year":"2007","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.autrev.2014.08.040_bb0275","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.autrev.2013.05.004","article-title":"Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab","volume":"12","author":"Berman","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.040_bb0280","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/art.37759","article-title":"A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome","volume":"65","author":"Erkan","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.040_bb0285","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MD.0b013e318190f170","article-title":"A systematic review of the off-label use of biological therapies in systemic autoimmune diseases","volume":"87","author":"Ramos-Casals","year":"2008","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"10.1016\/j.autrev.2014.08.040_bb0290","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1177\/0961203312446386","article-title":"Vitamin D and antiphospholipid syndrome","volume":"21","author":"Andreoli","year":"2012","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.040_bb0295","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1136\/annrheumdis-2013-203622","article-title":"A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients","volume":"73","author":"Erkan","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.040_bb0300","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-0897.2008.00585.x","article-title":"Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion","volume":"60","author":"Winger","year":"2008","journal-title":"Am J Reprod Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.040_bb0305","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1600-0897.2008.00669.x","article-title":"Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF","volume":"61","author":"Winger","year":"2009","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.autrev.2014.08.040_bb0310","doi-asserted-by":"crossref","unstructured":"Winger EE, Reed JL, Ashoush S, El-Toukhy T, Ahuja S, Taranissi M. Degree of TNF-alpha\/IL-10 cytokine elevation correlates with IVF success rates in women undergoing treatment with Adalimumab (Humira) and IVIG. Am J Reprod Immunol. Jun;65(6):610-8.","DOI":"10.1111\/j.1600-0897.2010.00946.x"},{"key":"10.1016\/j.autrev.2014.08.040_bb0315","doi-asserted-by":"crossref","unstructured":"Winger EE, Reed JL, Ashoush S, El-Toukhy T, Taranissi M. Die-off ratio correlates with increased TNF-alpha:IL-10 ratio and decreased IVF success rates correctable with humira. Am J Reprod Immunol. Nov;68(5):428\u201337.","DOI":"10.1111\/j.1600-0897.2012.01179.x"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.040_bb0320","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/0961203310361489","article-title":"Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?","volume":"19","author":"Pierangeli","year":"2010","journal-title":"Lupus"},{"issue":"11","key":"10.1016\/j.autrev.2014.08.040_bb0325","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2009-04-213520","article-title":"Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug","volume":"115","author":"Rand","year":"2010","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.autrev.2014.08.040_bb0330","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1161\/01.CIR.96.12.4380","article-title":"Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice","volume":"96","author":"Edwards","year":"1997","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.040_bb0335","doi-asserted-by":"crossref","first-page":"576.e7","DOI":"10.1016\/j.ajog.2011.06.064","article-title":"Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression","volume":"205","author":"Wu","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"5923","key":"10.1016\/j.autrev.2014.08.040_bb0340","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/bmj.3.5923.94","article-title":"Prevention of postoperative deep venous thrombosis in legs by orally administered hydroxychloroquine sulphate","volume":"3","author":"Carter","year":"1974","journal-title":"Br Med J"},{"issue":"7","key":"10.1016\/j.autrev.2014.08.040_bb0345","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2106\/00004623-197658070-00003","article-title":"Prevention of venous thromboembolism by administration of hydroxychloroquine. A preliminary report","volume":"58","author":"Chrisman","year":"1976","journal-title":"J Bone Joint Surg Am"},{"issue":"9","key":"10.1016\/j.autrev.2014.08.040_bb0350","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/0961203306071872","article-title":"Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus","volume":"15","author":"Ruiz-Irastorza","year":"2006","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.040_bb0355","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.2008.101766","article-title":"Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review","volume":"69","author":"Ruiz-Irastorza","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2014.08.040_bb0360","doi-asserted-by":"crossref","unstructured":"Shinjo SK, Bonfa E, Wojdyla D, Borba EF, Ramirez LA, Scherbarth HR, et al. Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort. Arthritis Rheum. Mar;62(3):855\u201362.","DOI":"10.1002\/art.27300"},{"issue":"9","key":"10.1016\/j.autrev.2014.08.040_bb0365","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/ard.2006.068676","article-title":"Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)","volume":"66","author":"Alarcon","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.040_bb0370","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3899\/jrheum.120157","article-title":"Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and\/or lupus anticoagulant in systemic lupus erythematosus","volume":"40","author":"Broder","year":"2013","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2014.08.040_bb0375","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.autrev.2013.04.006","article-title":"Preventing congenital neonatal heart block in offspring of mothers with anti-SSA\/Ro and SSB\/La antibodies: a review of published literature and registered clinical trials","volume":"12","author":"Gleicher","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.040_bb0380","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.autrev.2013.08.003","article-title":"Letter to the Editor in response to the article \u201cPreventing congenital neonatal heart block in offspring of mothers with anti-SSA\/Ro and SSB\/La antibodies: a review of published literature and registered clinical trials.\u201d","volume":"13","author":"Costedoat-Chalumeau","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.040_bb0385","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.089268","article-title":"Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA\/Ro-antibody-associated cardiac manifestations of neonatal lupus","volume":"126","author":"Izmirly","year":"2012","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.autrev.2014.08.040_bb0390","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/jth.12363","article-title":"Anti-thrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients","volume":"11","author":"Schmidt-Tanguy","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1016\/j.autrev.2014.08.040_bb0395","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/0961203312437810","article-title":"APS ACTION\u2014AntiPhospholipid Syndrome Alliance For Clinical Trials and InternatiOnal Networking","volume":"21","author":"Erkan","year":"2012","journal-title":"Lupus"},{"issue":"Suppl. 3","key":"10.1016\/j.autrev.2014.08.040_bb0400","first-page":"iii23","article-title":"Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers","volume":"47","author":"Erkan","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.040_bb0405","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.autrev.2014.01.053","article-title":"14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends","volume":"13","author":"Erkan","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.autrev.2014.08.040_bb0410","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1002\/art.22156","article-title":"Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus","volume":"54","author":"Costedoat-Chalumeau","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.autrev.2014.08.040_bb0415","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1136\/annrheumdis-2012-202322","article-title":"Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)","volume":"72","author":"Costedoat-Chalumeau","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.040_bb0420","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1136\/ard.2006.067835","article-title":"Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus","volume":"66","author":"Costedoat-Chalumeau","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2014.08.040_bb0425","doi-asserted-by":"crossref","unstructured":"Costedoat-Chalumeau N, Pouchot J, Guettrot-Imbert G, Le Guern V, Leroux G, Marra D, et al. Adherence to treatment in systemic lupus erythematosus patients. Best Pract Res Clin Rheumatol. Jun;27(3):329\u201340.","DOI":"10.1016\/j.berh.2013.07.001"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.040_bb0430","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/rheumatology\/kel402","article-title":"Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases","volume":"46","author":"Costedoat-Chalumeau","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.040_bb0435","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ophtha.2010.11.017","article-title":"Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy","volume":"118","author":"Marmor","year":"2011","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.040_bb0440","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.autrev.2004.11.009","article-title":"Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature","volume":"4","author":"Costedoat-Chalumeau","year":"2005","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.autrev.2014.08.040_bb0445","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.3899\/jrheum.110686","article-title":"Ocular toxicity in children exposed in utero to antimalarial drugs: review of the literature","volume":"38","author":"Osadchy","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2014.08.040_bb0450","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1546-0096-7-9","article-title":"Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases","volume":"7","author":"Sperber","year":"2009","journal-title":"Pediatr Rheumatol Online J"},{"issue":"11","key":"10.1016\/j.autrev.2014.08.040_bb0455","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1002\/art.11304","article-title":"Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group","volume":"48","author":"Costedoat-Chalumeau","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.040_bb0460","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/sj.jp.7211208","article-title":"Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation","volume":"25","author":"Motta","year":"2005","journal-title":"J Perinatol"},{"key":"10.1016\/j.autrev.2014.08.040_bb0465","series-title":"Lupus Erythemateux Systemique: Protocole National de diagnostic et de soins HAS","author":"PNDS","year":"2010"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214001840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214001840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T03:40:53Z","timestamp":1717299653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997214001840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S1568997214001840"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2014.08.040","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obstetrical APS: Is there a place for hydroxychloroquine to improve the pregnancy outcome?","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2014.08.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}